Add to comparison table
Financial Performance
5Y price score: 38
The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.
A score of 100 indicates that the stock did as well as the S&P 500 Index.
A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.
10Y return: 92%
DATE RANGE:
Latest quarterly dividend amount:$ 0.94
Current annual dividend yield:0.45%
%
US$ Per
Share
Latest Dividends
Previous dividend
Next dividend
Status
Paid
Declared
Type
Quarterly
Quarterly
Per share
$ 0.94
$ 0.94
Declaration date
Date when the company officially announced the dividend.
Wed, Apr 29, 2026
Thu, Jul 30, 2026
Ex-dividend date
Shown from the source record date field used for this dividends dataset.
Wed, May 20, 2026
Tue, Aug 18, 2026
Pay date
Date when the dividend is paid or scheduled to be paid to shareholders.
Thu, Jun 04, 2026
Mon, Aug 31, 2026
Dividend History
Declaration date
Record date
Payment date
Adj. dividend 
Adjusted for splits
Dividend
Type
Yield
01ㅤ
Thu, Jul 30, 2026
Tue, Aug 18, 2026
Mon, Aug 31, 2026
$ 0.94
$ 0.94
Quarterly
0.46%
02ㅤ
Wed, Apr 29, 2026
Wed, May 20, 2026
Thu, Jun 04, 2026
$ 0.94
$ 0.94
Quarterly
0.56%
03ㅤ
Fri, Jan 30, 2026
Fri, Feb 20, 2026
Thu, Mar 05, 2026
$ 0.94
$ 0.94
Quarterly
0.46%
04ㅤ
Tue, Oct 28, 2025
Thu, Nov 20, 2025
Fri, Dec 05, 2025
$ 0.88
$ 0.88
Quarterly
0.48%
05ㅤ
Fri, Aug 01, 2025
Mon, Aug 18, 2025
Wed, Sep 03, 2025
$ 0.88
$ 0.88
Quarterly
0.46%
06ㅤ
Tue, Apr 29, 2025
Tue, May 20, 2025
Fri, Jun 06, 2025
$ 0.88
$ 0.88
Quarterly
0.29%
07ㅤ
Tue, Feb 04, 2025
Thu, Feb 20, 2025
Thu, Mar 20, 2025
$ 0.88
$ 0.88
Quarterly
0.13%
Regeneron Pharmaceuticals (REGN) dividend history and yield
Review Regeneron Pharmaceuticals (REGN) dividends, including the latest declared payments, historical payout amounts, ex-dividend dates, payment dates, and dividend yield trends.
Use this dividend record to compare payout consistency, changes in shareholder distributions, and the role of dividends in a long-term investment analysis.